152 related articles for article (PubMed ID: 37968051)
21. Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo[1,5-a]pyrimidine analogues as potential anti-tubercular agents.
Modi P; Patel S; Chhabria M
Bioorg Chem; 2019 Jun; 87():240-251. PubMed ID: 30908967
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and characterization of ethyl 3-benzoyl-7-morpholinoindolizine-1-carboxylate as anti-tubercular agents: In silico screening for possible target identification.
Tiwari P; Mangubhai GS; Kidwai S; Singh R; Chandrashekharappa S
Chem Biol Drug Des; 2024 Apr; 103(4):e14512. PubMed ID: 38570316
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
[TBL] [Abstract][Full Text] [Related]
25. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
[TBL] [Abstract][Full Text] [Related]
26. Quinoline derivatives as potential anti-tubercular agents: Synthesis, molecular docking and mechanism of action.
Liu CX; Zhao X; Wang L; Yang ZC
Microb Pathog; 2022 Apr; 165():105507. PubMed ID: 35354076
[TBL] [Abstract][Full Text] [Related]
27. Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives.
Parwani D; Bhattacharya S; Rathore A; Mallick C; Asati V; Agarwal S; Rajoriya V; Das R; Kashaw SK
Mini Rev Med Chem; 2021; 21(5):643-657. PubMed ID: 33138762
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
29. Novel indolinone-tethered benzothiophenes as anti-tubercular agents against MDR/XDR M. tuberculosis: Design, synthesis, biological evaluation and in vivo pharmacokinetic study.
Eldehna WM; Mahmoud ST; Elshnawey ER; Elsayed ZM; Majrashi TA; El-Ashrey MK; Rashed M; Hemeda LR; Shoun AA; Elkaeed EB; El Hassab MA; Abdel-Aziz MM; Shahin MI
Bioorg Chem; 2024 Feb; 143():107009. PubMed ID: 38070474
[TBL] [Abstract][Full Text] [Related]
30. Discovery of novel antituberculosis agents among 3-phenyl-5-(1-phenyl-1H-[1,2,3]triazol-4-yl)-[1,2,4]oxadiazole derivatives targeting aminoacyl-tRNA synthetases.
Rybak MY; Balanda AO; Yatsyshyna AP; Kotey IM; Starosyla SA; Bdzhola VG; Lukash LL; Yarmoluk SM; Tukalo MA; Volynets GP
Sci Rep; 2021 Mar; 11(1):7162. PubMed ID: 33785838
[TBL] [Abstract][Full Text] [Related]
31. Bacterial FtsZ inhibition by benzo[
Dhameliya TM; Tiwari R; Patel KI; Vagolu SK; Panda D; Sriram D; Chakraborti AK
Future Med Chem; 2022 Oct; 14(19):1361-1373. PubMed ID: 36103222
[No Abstract] [Full Text] [Related]
32. Synthesis of New 3-Arylaminophthalides and 3-Indolyl-phthalides using Ammonium Chloride, Evaluation of their Anti-Mycobacterial Potential and Docking Study.
Patil A; Duggal H; Bagul KT; Kamble S; Lokhande P; Gacche R; Meshram R
Comb Chem High Throughput Screen; 2020; 23(8):723-739. PubMed ID: 32321396
[TBL] [Abstract][Full Text] [Related]
33. Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular.
Das R; Mehta DK
Drug Res (Stuttg); 2021 Jan; 71(1):26-35. PubMed ID: 33027823
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
Cordeiro R; Kachroo M
Bioorg Med Chem Lett; 2020 Dec; 30(24):127655. PubMed ID: 33130292
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, molecular docking, and biological evaluation of coumarin-thymidine analogs as potent anti-TB agents.
Reddy DS; Sinha A; Kurjogi MM; Shanavaz H; Kumar A
Arch Pharm (Weinheim); 2023 May; 356(5):e2200633. PubMed ID: 36634969
[TBL] [Abstract][Full Text] [Related]
36. Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
Patel H; Jadhav H; Ansari I; Pawara R; Surana S
Eur J Med Chem; 2019 Apr; 167():1-9. PubMed ID: 30743094
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, In silico and Biological Studies of Thiazolyl-2h-chromen-2-one Derivatives as Potent Antitubercular Agents.
Jadhav BS; Yamgar RS; Kenny RS; Mali SN; Chaudhari HK; Mandewale MC
Curr Comput Aided Drug Des; 2020; 16(5):511-522. PubMed ID: 31438831
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, anti-TB activities, and molecular docking studies of 4-(1,2,3-triazoyl)arylmethanone derivatives.
Turkmen Y; Yagiz Erdemir G; Yuksel Mayda P; Akdemir A; Gunaydin Akyildiz A; Altundas A
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22998. PubMed ID: 35187763
[TBL] [Abstract][Full Text] [Related]
39. Preparation, biological evaluation and molecular docking study of imidazolyl dihydropyrimidines as potential Mycobacterium tuberculosis dihydrofolate reductase inhibitors.
Desai NC; Trivedi AR; Khedkar VM
Bioorg Med Chem Lett; 2016 Aug; 26(16):4030-5. PubMed ID: 27397497
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of novel quinazolinyl-bisspirooxindoles as potent anti-tubercular agents: an ultrasound-promoted methodology.
Allaka BS; Basavoju S; Madhu Rekha E; Sriram D; Rama Krishna G
Mol Divers; 2023 Jun; 27(3):1427-1436. PubMed ID: 35933454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
